The relationship between art, beauty and self-expression is a close one. Galderma is fostering those ties as the exclusive aesthetic injectables sponsor of Scope Miami Beach, a showcase for emerging contemporary art.
Galderma set up on-site with a myriad of offerings and events showcasing its aesthetics range of Restylane, Dysport (abobotulinumtoxinA) and Sculptra. This event continues the "XpresYourself" campaign, which aims to destigmatize the use of aesthetics while celebrating self-expression and promoting the products' natural-looking results. Carrie Caulkins, Galderma’s vice president of U.S. aesthetics marketing, sees the event, which ran from the end of November to early December, as a great match for the brand and its message.
“It goes with our theme, which is every skin story starts with beautiful canvas. And so your skin is kind of your own canvas and your aesthetic look is kind of your way of expressing art in a different form,” she said. "For us, it was just a really great collaboration with Scope. To bring that through, because aesthetics is encouragement of self-expression.”
Part of that collaboration includes a custom installation for Galderma’s interactive space by the street artist HOTTEA. There was also a coffee bar featuring latte art and giveaways as well as $200 off Galderma Aesthetics treatments through a special ASPIRE Galderma Rewards offer.
Galderma also offered on-site consults and even injection treatments with its local aestheticians, as well as beauty tips and make up touch-ups from celebrity makeup artist Jamie Greenberg. There were also meet and greets with beauty influencers Tinx and Kelley Flanagan.
“We really embrace and encourage one’s self expression through the art of aesthetics. So we strive to innovate and deliver products that allow patients to fully express their range of emotions while looking their best. We wanted to ensure our message to our consumers here was to encourage a potential set of users to trust Galderma with their beauty goals, and we hope to convert any current patients that may not be familiar with our products,” Caulkins said.
Galderma’s dermo-cosmetics franchise is booming with revenue growth of 31% year over year in the first half of 2022. The Swiss drugmaker’s skin cleanser Cetaphil along with product launches in China and the rest of Asia contributed to the increase. The pharma is looking to expand with preliminary stages of building a manufacturing facility in Singapore to support its growth in the Asia-Pacific region.